(Q36984958)

17 August 2017

1 reference

title

Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs (English)

1 reference

17 August 2017

Jan Booij

1

1 reference

PubMed ID

17968545

17 August 2017

Paul Kemp

series ordinal

2

1 reference

PubMed ID

17968545

17 August 2017

language of work or name

1 reference

30 October 2007

1 reference

17 August 2017

15

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

17 August 2017

35

1 reference

17 August 2017

2

1 reference

17 August 2017

424-438

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-007-0621-0

17 August 2017

0 references

cites work

Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0621-0

Measurement of cerebral monoamine oxidase B activity using L-[11C]deprenyl and dynamic positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0621-0

Anorectics on trial: a half century of federal regulation of prescription appetite suppressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0621-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0621-0

Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0621-0

Modulation of brain dopamine transmission by sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0621-0

Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0621-0

Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT.

21 January 2018

1 reference

12 December 2020

Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle

1 reference

12 December 2020

Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography

1 reference

12 December 2020

Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants

1 reference

12 December 2020

Modafinil binds to the dopamine uptake carrier site with low affinity.

1 reference

12 December 2020

Dopaminergic role in stimulant-induced wakefulness.

1 reference

12 December 2020

N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter.

1 reference

12 December 2020

Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum

1 reference

12 December 2020

Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain

1 reference

12 December 2020

Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

1 reference

12 December 2020

Fentanyl decreases beta-CIT binding to the dopamine transporter

1 reference

12 December 2020

Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine

1 reference

12 December 2020

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

1 reference

12 December 2020

Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.

1 reference

12 December 2020

Dopamine transporters are phosphorylated on N-terminal serines in rat striatum

1 reference

12 December 2020

In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.

1 reference

12 December 2020

Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine

1 reference

12 December 2020

Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants

1 reference

12 December 2020

Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors

1 reference

12 December 2020

Alternatives to levodopa in the initial treatment of early Parkinson's disease

1 reference

12 December 2020

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

1 reference

12 December 2020

Isoflurane induces dopamine transporter trafficking into the cell cytoplasm

1 reference

12 December 2020

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

12 December 2020

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

1 reference

12 December 2020

Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait.

1 reference

12 December 2020

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

1 reference

12 December 2020

Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects.

1 reference

12 December 2020

Reinforcing effect of pseudoephedrine isomers and the mechanism of action

1 reference

12 December 2020

Relationship between subjective effects of cocaine and dopamine transporter occupancy.

1 reference

12 December 2020

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

1 reference

12 December 2020

Membrane trafficking regulates the activity of the human dopamine transporter

1 reference

12 December 2020

[123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.

1 reference

12 December 2020

Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram

1 reference

12 December 2020

The 2006 Henry N. Wagner Lecture: Of mice and men (and positrons)--advances in PET imaging technology.

1 reference

12 December 2020

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

1 reference

12 December 2020

Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.

1 reference

12 December 2020

Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study

1 reference

12 December 2020

Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography.

1 reference

12 December 2020

Increased dopamine uptake in striatal synaptosomes after treatment of rats with amantadine

1 reference

12 December 2020

The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: a quantitative autoradiography study

1 reference

12 December 2020

In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography

1 reference

12 December 2020

Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression

1 reference

12 December 2020

Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain

1 reference

12 December 2020

Enhancement of [123I]beta-CIT binding in the striatum with clomipramine: is there a serotonin-dopamine interaction?

1 reference

12 December 2020

Pilot study on the effect of estrogen replacement therapy on brain dopamine transporter availability in healthy, postmenopausal women

1 reference

12 December 2020

Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo

1 reference

12 December 2020

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

1 reference

12 December 2020

Role of dopamine transporter imaging in routine clinical practice

1 reference

12 December 2020

Striatal dopaminergic and serotonergic markers in human heroin users

1 reference

12 December 2020

Imaging of dopamine transporters in humans with technetium-99m TRODAT-1

1 reference

12 December 2020

In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates

1 reference

12 December 2020

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

1 reference

12 December 2020

In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783

1 reference

12 December 2020

Synthesis and biological evaluation of meperidine analogues at monoamine transporters

1 reference

12 December 2020

Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases

1 reference

12 December 2020

Levodopa and the progression of Parkinson's disease

1 reference

12 December 2020

A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.

1 reference

12 December 2020

Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.

1 reference

12 December 2020

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

1 reference

12 December 2020

Cocaine: pharmacokinetics and biotransformation in man.

1 reference

12 December 2020

[3H]beta-CIT: a radioligand for dopamine transporters in rat brain tissue.

1 reference

12 December 2020

Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.

1 reference

12 December 2020

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease

1 reference

12 December 2020

Changes of dopamine transporter function in striatum during acute morphine addiction and its abstinence in rhesus monkey.

1 reference

12 December 2020

Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17.

1 reference

12 December 2020

The pinhole: gateway to ultra-high-resolution three-dimensional radionuclide imaging

1 reference

12 December 2020

Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report

1 reference

12 December 2020

Dopamine visualized in the basal ganglia of living man.

1 reference

12 December 2020

Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

1 reference

12 December 2020

Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).

1 reference

12 December 2020

Valvular heart disease associated with fenfluramine-phentermine

1 reference

12 December 2020

One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.

1 reference

12 December 2020

Pharmacological profile of neuroleptics at human monoamine transporters

1 reference

12 December 2020

Rivastigmine for dementia associated with Parkinson's disease

1 reference

12 December 2020

[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease

1 reference

12 December 2020

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

1 reference

12 December 2020

Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers

1 reference

12 December 2020

Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes

1 reference

12 December 2020

Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain

1 reference

12 December 2020

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

12 December 2020

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

12 December 2020

Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.

1 reference

12 December 2020

Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.

1 reference

12 December 2020

[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain

1 reference

12 December 2020

[123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts

1 reference

12 December 2020

N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

1 reference

12 December 2020

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

1 reference

12 December 2020

Drugs for Parkinson's disease

1 reference

12 December 2020

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.

1 reference

12 December 2020

The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter.

1 reference

12 December 2020

Synthesis, dopamine and serotonin transporter binding affinities of novel analogues of meperidine

1 reference

12 December 2020

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate

1 reference

12 December 2020

Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55.

1 reference

12 December 2020

Regulation of the dopamine transporter by phosphorylation.

1 reference

12 December 2020

Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration

1 reference

12 December 2020

Opposing effects of clomipramine on [125I]RTI-55 and [3H]N-methylspiperone binding in mouse striatum: important role of other factors than endogenous dopamine?

1 reference

12 December 2020

Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.

1 reference

12 December 2020

Basic pharmacokinetic principles and their application to psychotropic drugs.

1 reference

12 December 2020

Ketamine stereoselectively inhibits rat dopamine transporter

1 reference

12 December 2020

Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism

1 reference

12 December 2020

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

1 reference

12 December 2020

Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.

1 reference

12 December 2020

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

1 reference

12 December 2020

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

12 December 2020

The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects

1 reference

12 December 2020

Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?

1 reference

12 December 2020

The effect of levodopa therapy on dopamine transporter SPECT imaging with( 123)I-FP-CIT in patients with Parkinson's disease

1 reference

12 December 2020

Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum

1 reference

12 December 2020

Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography

1 reference

12 December 2020

Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands.

1 reference

12 December 2020

Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.

1 reference

12 December 2020

Pharmacokinetic aspects of l-deprenyl (selegiline) and its metabolites

1 reference

12 December 2020

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

1 reference

12 December 2020

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence

1 reference

12 December 2020

Cholinergic neuronal modulations affect striatal dopamine transporter activity: PET studies in the conscious monkey brain

1 reference

12 December 2020

Phenylephrine and norepinephrine increase dopamine transporter ligand binding in striatum

1 reference

12 December 2020

Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis

1 reference

12 December 2020

Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine

1 reference

12 December 2020

Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters

1 reference

12 December 2020

[123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication

1 reference

12 December 2020

Chronic morphine alters dopamine transporter density in the rat brain: possible role in the mechanism of drug addiction

1 reference

12 December 2020

PET examination of the monoamine transporter with [11C]beta-CIT and [11C]beta-CFT in early Parkinson's disease.

1 reference

12 December 2020

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

1 reference

12 December 2020

Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study.

1 reference

12 December 2020

Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice.

1 reference

12 December 2020

Patterns of recreational drug use at dance events in Edinburgh, Scotland

1 reference

12 December 2020

Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.

1 reference

12 December 2020

Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors.

1 reference

12 December 2020

Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction

1 reference

12 December 2020

Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes

1 reference

12 December 2020

Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain

1 reference

12 December 2020

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.

1 reference

12 December 2020

Ephedrine abuse among 36 female weightlifters

1 reference

12 December 2020

10.1007/S00259-007-0621-0

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17968545